Search results for "GROWTH HORMONE"

showing 10 items of 156 documents

Effects of heavy resistance/power training on maximal strength, muscle morphology, and hormonal response patterns in 60-75-year-old men and women.

2002

Eleven women (TRW; 64 ± 4 yrs) and ten men (TRM; 65 ± 5 yrs) participated in the strength/power training twice a week for 24 weeks. Basal concentrations of serum total and free testosterone, growth hormone (GH), dehydroepiandrosterone sulfate (DHEAS), cortisol and sex hormone binding globulin (SHBG) as well as acute responses of serum total and free testosterone, growth hormone (GH) were measured. Maximal 1RM strength in the squat, chair rise time and muscle fibre distribution and areas of type I and IIa and IIb of the vastus lateralis were also examined. 1RM squat increased in TRW by 26 (SDIO) % (p < .001), and in TRM by 35(7) % (p < .001) and chair rise time improved in both groups…

Malemedicine.medical_specialtyPhysiologyMuscle Fibers SkeletalMuscle hypertrophyBasal (phylogenetics)Muscle morphologyInternal medicineMaximal strengthmedicineHumansOrthopedics and Sports MedicineGonadal Steroid HormonesMuscle SkeletalExerciseTestosteroneAgedFree testosteronebusiness.industryHypertrophyMiddle AgedHormonesEndocrinologyGrowth HormoneFemalebusinessHormonal responseCanadian journal of applied physiology = Revue canadienne de physiologie appliquee
researchProduct

The Adult Pituitary Shows Stem/Progenitor Cell Activation in Response to Injury and Is Capable of Regeneration

2012

The pituitary gland constitutes, together with the hypothalamus, the regulatory core of the endocrine system. Whether the gland is capable of cell regeneration after injury, in particular when suffered at adult age, is unknown. To investigate the adult pituitary's regenerative capacity and the response of its stem/progenitor cell compartment to damage, we constructed a transgenic mouse model to conditionally destroy pituitary cells. GHCre/iDTR mice express diphtheria toxin (DT) receptor after transcriptional activation by Cre recombinase, which is driven by the GH promoter. Treatment with DT for 3 d leads to gradual GH+ (somatotrope) cell obliteration with a final ablation grade of 80–90% 1…

Malemedicine.medical_specialtyPituitary glandTime FactorsSomatotropic cellMice TransgenicBiologyMiceEndocrinologySOX2Internal medicinemedicineAnimalsRegenerationCell LineageProgenitor cellPromoter Regions GeneticSOXB1 Transcription FactorsStem CellsDeoxyuridineEndothelial stem cellEndocrinologymedicine.anatomical_structureGrowth HormonePituitary GlandIntercellular Signaling Peptides and ProteinsFemaleStem cellHeparin-binding EGF-like Growth FactorAdult stem cellEndocrine glandEndocrinology
researchProduct

Janus kinase (JAK) 2 V617F mutation as the cause of primary thrombocythemia in acromegaly with severe visceromegaly and divergence between growth hor…

2012

OBJECTIVE: An increased prevalence of hematological abnormalities is reported in acromegaly, but to date no reports about the presence of the Janus Kinase (JAK) 2 mutation in acromegalic patients have been described. DESIGN: We report the complex clinical presentation of the unique case, never described, of acromegaly due to GH-secreting pituitary adenoma associated with JAK2 V617F mutation. RESULTS: The patient shows primary thrombocythemia and myelofibrosis, due to JAK2 V617F mutation, severe visceromegaly and a peculiar clinical course of the disease characterized by discrepant values of GH and IGF-1 during somatostatin analog (SA) treatment despite a significant reduction in pituitary a…

Malemedicine.medical_specialtyTime FactorsEndocrinology Diabetes and MetabolismGrowth hormone receptorAcromegaly HGH IGF-1GastroenterologySettore MED/13 - EndocrinologiaCohort StudiesEndocrinologyPituitary adenomahemic and lymphatic diseasesInternal medicineAcromegalymedicineAnimalsHumansPituitary NeoplasmsInsulin-Like Growth Factor IRadiometryMyelofibrosisAgedJanus kinase 2biologyHuman Growth HormonePlatelet Countbusiness.industryJanus Kinase 2medicine.diseaseAcromegaly Growth hormone Insulin-like growth factor-1 Janus kinase 2 Growth hormone receptorEndocrinologyAcromegalyMutationPegvisomantbiology.proteinJanus kinasebusinessVisceromegalyFollow-Up StudiesThrombocythemia Essentialmedicine.drug
researchProduct

Acute hormonal and neuromuscular responses and recovery to forced vs maximum repetitions multiple resistance exercises.

2003

Acute hormonal and neuromuscular responses and recovery three days after the exercises were examined during the maximum repetitions (MR) and forced repetitions (FR) resistance exercise protocols in 16 male athletes. MR included 4 sets of leg presses, 2 sets of squats and 2 sets of knee extensions (with 12 RM) with a 2-min recovery between the sets and 4 min between the exercises. In FR the initial load was chosen to be higher than in MR so that the subject could not lift 12 repetitions per set by himself. After each set to failure the subject was assisted to perform the remaining repetitions to complete the 12 repetitions per set. Thus the exercise intensity was greater in FR than in MR. Bo…

Malemedicine.medical_specialtyTime FactorsHydrocortisoneWeight LiftingPainPhysical Therapy Sports Therapy and RehabilitationIsometric exerciseElectromyographyPhysical medicine and rehabilitationInternal medicineIsometric ContractionMedicineHumansOrthopedics and Sports MedicineHormone metabolismTestosteroneLactic AcidExercise physiologyMuscle SkeletalExerciseSerum testosteronemedicine.diagnostic_testbusiness.industryElectromyographyHuman Growth HormoneResistance trainingHormonesElectrophysiologyExercise intensityCardiologybusinessHormoneInternational journal of sports medicine
researchProduct

Revaluation of the clinical and metabolic behavior of children with isolated growth hormone deficiency during GH treatment according to newly propose…

2015

Purpose To evaluate the clinical and metabolic behavior of children with isolated growth hormone (GH)-deficiency (GHD), grouped according to the new AIFA criteria for the appropriateness of use and reimbursement of GH treatment in children. Methods The clinical and metabolic data of 310 prepubertal children (220 M, 90 F; mean age 10.8 years) grouped, according to new AIFA note 39, into group A (No 181 with a peak of GH 10 µg/L) were retrospectively analyzed. Group A and B, diagnosed as having GHD, were treated with GH for at least 24 months, while group C was analyzed only at baseline. Results At baseline, group A showed higher waist circumference than B (p=0.031) and C (p=0.041), while no …

Malemedicine.medical_specialtyWaistAdolescentEndocrinology Diabetes and Metabolismmedicine.medical_treatmentGroup AGroup BGrowth hormone deficiencySettore MED/13 - Endocrinologiachemistry.chemical_compoundGovernment AgenciesEndocrinologyInternal medicineOutcome Assessment Health CaremedicineHumansChildDwarfism PituitaryGrowth hormone childrenbusiness.industryCholesterolInsulinmedicine.diseaseEndocrinologyItalychemistryChild PreschoolGrowth HormoneConcomitantPractice Guidelines as TopicGh treatmentFemalebusinessFollow-Up Studies
researchProduct

Basal growth hormone concentrations in blood and the risk for prostate cancer: A case-control study

2005

OBJECTIVE To assess the relationship between basal serum growth hormone (GH) levels and prostate cancer risk. METHODS We conducted a population-based case-control study; cases included 68 men, aged 45–85 years, diagnosed with incident, primary, histologically confirmed, and clinically apparent (stage B and higher) prostate cancer. Controls included 240 men, frequency matched on age and residential area. Age, race, BMI, waist circumference, history of enlarged prostate, education, and current smoking status, were all considered as possible confounders. RESULTS We found a statistically significant trend of decreasing prostate cancer risk across increasing GH quintiles, in both crude (OR: 0.31…

Malemedicine.medical_specialtyWaistUrologyPopulationGastroenterologyProstate cancerBasal (phylogenetics)Risk FactorsInternal medicineBiomarkers TumormedicineHumansInsulin-Like Growth Factor IRisk factoreducationAgedAged 80 and overeducation.field_of_studybusiness.industryConfoundingCase-control studyProstatic NeoplasmsMiddle Agedmedicine.diseaseGrowth hormone secretionEndocrinologyOncologyCase-Control StudiesGrowth HormonebusinessThe Prostate
researchProduct

Prolactin secretion before, during, and after chronic gonadotropin-releasing hormone agonist treatments in children.

2005

Objective To examine the effect of long-term administration of GnRH agonists (GnRHa) on PRL secretion in children affected by central precocious puberty (CPP) and growth hormone deficiency (GHD). Design Prospective analysis of blood sampling before, during, and after GnRHa treatments. Setting Pediatric endocrine center. Patient(s) One hundred nineteen and 93 children with a diagnosis of CPP and GHD, respectively. Intervention(s) Monthly depot injections of GnRHa drugs (leuprorelin acetate 3.75 mg [LA] and triptorelin 3.75 mg [TR]) administered to CPP and GHD patients for 40 and 24 months, respectively. Main Outcome Measure(s) Serum PRL levels at baseline and after 6, 12, 18, 24, 30, 36, and…

Malemedicine.medical_specialtymedicine.drug_classPuberty PrecociousGonadotropin-releasing hormoneGrowth hormone deficiencyGonadotropin-Releasing HormoneLeuprorelinInternal medicineGonadotropin-releasing hormone agonistmedicinePrecocious pubertyHumansProspective StudiesChildbusiness.industryHuman Growth HormoneObstetrics and Gynecologymedicine.diseaseTriptorelinProlactinProlactinEndocrinologyReproductive MedicineChild PreschoolFemalebusinessBlood samplingmedicine.drugFertility and sterility
researchProduct

The effects of insulin on transport and metabolism of glucose in skeletal muscle from hyperthyroid and hypothyroid rats.

1997

The effects of insulin on the rates of glucose disposal were studied in soleus muscles isolated from hyper- or hypothyroid rats. Treatment with triiodothyronine for 5 or 10 days decreased the sensitivity of glycogen synthesis but increased the sensitivity of lactate formation to insulin. The sensitivity of 3-O methylglucose to insulin was increased only after 10 days of treatment and was accompanied by an increase in the sensitivity of 2-deoxyglucose phosphorylation; however, 2-deoxyglucose and glucose 6-phosphate in response to insulin remained unaltered. In hypothyroidism, insulin-stimulated rates of 3-O-methylglucose transport and 2-deoxyglucose phosphorylation were decreased; however, a…

Malemedicine.medical_specialtymedicine.medical_treatmentClinical BiochemistryBiological Transport ActiveBiologyCarbohydrate metabolismIn Vitro TechniquesBiochemistryHyperthyroidismDinoprostonechemistry.chemical_compoundHypothyroidismInternal medicinemedicineAnimalsInsulinGlycolysisDrug InteractionsLactic AcidPhosphorylationRats WistarGlycogen synthaseMuscle SkeletalHexokinaseInsulinGlucose transporterGeneral MedicineMetabolismRatsCortisoneEndocrinologyGlucosechemistryBasal (medicine)Growth Hormonebiology.proteinTriiodothyronineGlycolysisGlycogenEuropean journal of clinical investigation
researchProduct

Effects of a GH polymorphism on milk production traits in Modicana and Cinisara cows reared in different feeding systems.

2019

Growth hormone, a polypeptide encoded by the GH gene, is a member of the somatotropin/prolactin family of hormones, which plays an important role on milk production and metabolism. In bovine, a single nucleotide polymorphism (SNP) in exon 5 changes leucine to valine (CTG to GTG) in the mature GH molecule. The purpose of this study was to evaluate, in Modicana and Cinisara cows, the effects of genetic polymorphism at GH locus and its interaction with feeding system on milk traits. A total of 97 individual Modicana blood samples were collected, 65 from a semi extensive and 32 from an extensive farm. A total of 58 Cinisara individual milk samples were collected, 32 from 7 extensive farms and 2…

Modicana and Cinisara cowSettore AGR/19 - Zootecnica Specialemilk production and metabolismgenetic polymorphismGrowth hormone
researchProduct

Nocturnal hormone profiles in patients with schizophrenia treated with olanzapine.

2005

Summary Nocturnal hormone profiles were measured in patients with schizophrenia with predominantly negative symptoms both under drug-free baseline conditions and after subchronic administration of the atypical antipsychotic olanzapine, with the aim of characterizing its pharmacological properties on the neuroendocrine level. The following hormones were studied in the sleep laboratory under polysomnographic control: adrenocorticotrophic hormone, cortisol, growth hormone (GH), prolactin, testosterone, and melatonin. Blood samples were taken at regular time intervals over the night, and serum concentrations of the hormones were determined. Ten patients completed the study, two of them were exc…

OlanzapineAdultMalemedicine.medical_specialtyHydrocortisonemedicine.drug_classEndocrinology Diabetes and MetabolismAtypical antipsychoticMelatoninBenzodiazepinesEndocrinologyAdrenocorticotropic HormoneInternal medicinemedicineHumansTestosteroneCircadian rhythmBiological PsychiatryTestosteroneMelatoninInpatientsEndocrine and Autonomic SystemsDopamine antagonistProlactinCircadian RhythmProlactinPsychiatry and Mental healthEndocrinologyOlanzapineGrowth HormoneSchizophreniaPsychologySleepmedicine.drugHormoneAntipsychotic AgentsPsychoneuroendocrinology
researchProduct